Changes in monoclonal HLA-DR antigen expression in acute organophosphorus pesticide-poisoned patients

Experimental and Therapeutic Medicine

Volumn 7, Issue 1, 2013, Pages 137-140

  Xia, Chenyun ^a   Wang, Mi ^b   Liang, Qi ^a   Yun, Ling'an ^a   Kang, Housheng ^a   Fan, Lei ^a   Wang, Dongsheng ^a   Zhang, Guoyuan ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Acute organophosphate pesticide poisoning; Human leukocyte antigen DR; Multiple organ dysfunction syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLINESTERASE; CREATINE KINASE ISOENZYME; CREATININE; HLA DR ANTIGEN; LACTATE DEHYDROGENASE;

ADULT; AGED; APACHE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENETIC CORRELATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; ORGANOPHOSPHATE POISONING; PROGNOSIS; PROTEIN EXPRESSION; UREA NITROGEN BLOOD LEVEL;

EID: 84887926898     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1356     Document Type: Article

References (21)

1. Cavaliere MJ, Puga FR, Calore EE, et al: Protective effect of pralidoxime on muscle fiber necrosis induced by organophosphate compounds. J Toxicol Clin Toxicol 36: 295-300, 1998.
2. Mizuno Y, Ohama E, Hirato J, et al: Nestin immunoreactivity of Purkinje cells in Creutzfeldt-Jakob disease. J Neurol Sci 246: 131-137, 2006.
3. Lukaszewicz AC, Faivre V and Payen D: Is monocyte HLA-DR expression monitoring a useful tool to predict the risk of secondary infection? Minerva Anestesiol 76: 737-743, 2010.
4. Itakura Sumi Y, Ogura H, Tanaka H, et al: Paradoxical cytoskeleton and microparticle formation changes in monocytes and polymorphonuclear leukocytes in severe systemic inflammatory response syndrome patients. J Trauma 55: 1125-1132, 2003.
5. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M and Mochizuki H: Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 188: 150-156, 2004.
6. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655, 1992.
7. Knaus WA, Draper EA, Wagner DP and Zimmerman JE: APACHE II: a severity of disease classification system. CritCareMed 13: 818-829, 1985.
8. Chiba M, Ishii N, Ishioka T, et al: Topographic study of Helicobacter pylori and HLA-DR antigen expression on gastric epithelium. J Gastroenterol 30: 149-155, 1995.
9. Wakefield CH, Carey PD, Foulds S, Monson JR and Guillou PJ: Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 80: 205-209, 1993.
10. Klava A, Windsor A, Boylston AW, Reynolds JV, Ramsden CW and Guillou PJ: Monocyte activation after open and laparoscopic surgery. Br J Surg 84: 1152-1156, 1997.
11. Tschoeke SK and Ertel W: Immunoparalysis after multiple trauma. Injury 38: 1346-1357, 2007.
12. Cheron A, Floccard B, Allaouchiche B, et al: Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 14: R208, 2010.
13. Ho YP, Sheen IS, Chiu CT, Wu CS and Lin CY: A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. AmJGastroenterol 101: 1117-1124, 2006.
14. Chadban SJ, Tesch GH, Foti R, Lan HY, Atkins RC and Nikolic-Paterson DJ: Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo. Immunology 94: 72-78, 1998.
15. Otsuka A, Hanafusa T, Kono N and Tarui S: Lipopolysaccharide augments HLA-A, B, C molecule expression but inhibits interferon-gamma-induced HLA-DR molecule expression on cultured human endothelial cells. Immunology 73: 428-432, 1991.
16. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF and Polk HC Jr: Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77: 204-207, 1990.
17. Melhus O, Koerner TJ and Adams DO: Effects of TNF alpha on the expression of class II MHC molecules in macrophages induced by IFN gamma: evidence for suppression at the level of transcription. J Leukoc Biol 49: 21-28, 1991.
18. Bone RC, Grodzin CJ and Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112: 235-243, 1997.
19. Volk HD, Reinke P and Döcke WD: Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 74: 162-177, 2000.
20. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F and GogosCA: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol11: 161-167, 2004.
21. Ploder M, Pelinka L, Schmuckenschlager C, et al: Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 25: 129-134, 2006.